{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:46:37Z","timestamp":1786977997850,"version":"build-2736575974"},"reference-count":51,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15CA143701"],"award-info":[{"award-number":["1R15CA143701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010937","name":"St. John's University","doi-asserted-by":"publisher","award":["579-1110-7002"],"award-info":[{"award-number":["579-1110-7002"]}],"id":[{"id":"10.13039\/100010937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Biochem."],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1002\/jcb.25908","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T22:57:10Z","timestamp":1485298630000},"page":"2420-2429","source":"Crossref","is-referenced-by-count":6,"title":["2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations"],"prefix":"10.1002","volume":"118","author":[{"given":"Rishil J.","family":"Kathawala","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy Health Sciences; St. John's University; Queens New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Li","sequence":"additional","affiliation":[{"name":"Key laboratory of Bioorganic Phosphorus and Chemical Biology; The Ministry of Education; Department of Chemistry; Tsinghua University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danwen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy Health Sciences; St. John's University; Queens New York"},{"name":"Laboratory of Dermatology; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery; Peking Union Medical College Hospital; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy Health Sciences; St. John's University; Queens New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Laboratory of Dermatology; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Key laboratory of Bioorganic Phosphorus and Chemical Biology; The Ministry of Education; Department of Chemistry; Tsinghua University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy Health Sciences; St. John's University; Queens New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"10.1002\/jcb.25908-BIB0001|jcb25908-cit-0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00001813-200603000-00001","article-title":"Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP\/ABCG2)","volume":"17","author":"Ahmed-Belkacem","year":"2006","journal-title":"Anticancer Drugs"},{"key":"10.1002\/jcb.25908-BIB0002|jcb25908-cit-0002","first-page":"2294","article-title":"A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance","volume":"62","author":"Allen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0003|jcb25908-cit-0003","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.3390\/molecules190913848","article-title":"Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance","volume":"19","author":"Anreddy","year":"2014","journal-title":"Molecules"},{"key":"10.1002\/jcb.25908-BIB0004|jcb25908-cit-0004","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1021\/jm0000923","article-title":"Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase","volume":"43","author":"Bebernitz","year":"2000","journal-title":"J Med Chem"},{"key":"10.1002\/jcb.25908-BIB0005|jcb25908-cit-0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152013804487380","article-title":"New insight into p-glycoprotein as a drug target","volume":"13","author":"Breier","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1002\/jcb.25908-BIB0006|jcb25908-cit-0006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/jpet.109.163493","article-title":"Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport","volume":"333","author":"Cai","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jcb.25908-BIB0007|jcb25908-cit-0007","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","article-title":"Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases","volume":"278","author":"Chen","year":"2011","journal-title":"FEBS J"},{"key":"10.1002\/jcb.25908-BIB0008|jcb25908-cit-0008","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1002\/jcb.25908-BIB0009|jcb25908-cit-0009","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1158\/0008-5472.CAN-08-0499","article-title":"Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2","volume":"68","author":"Dai","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0010|jcb25908-cit-0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1002\/jcb.25908-BIB0011|jcb25908-cit-0011","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jcb.25908-BIB0012|jcb25908-cit-0012","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0006-291X(88)80073-1","article-title":"Reduced cyclosporin accumulation in multidrug-resistant cells","volume":"152","author":"Goldberg","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jcb.25908-BIB0013|jcb25908-cit-0013","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1002\/jcb.25908-BIB0014|jcb25908-cit-0014","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/jcb.25908-BIB0015|jcb25908-cit-0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0165-6147(94)90082-5","article-title":"Anilide tertiary carbinols: A novel series of K+ channel openers","volume":"15","author":"Grant","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1002\/jcb.25908-BIB0016|jcb25908-cit-0016","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0925-4439(02)00095-9","article-title":"Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and M RP1","volume":"1587","author":"Hegedus","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jcb.25908-BIB0017|jcb25908-cit-0017","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jcb.25908-BIB0018|jcb25908-cit-0018","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5732\/cjc.013.10122","article-title":"Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs","volume":"33","author":"Kathawala","year":"2014a","journal-title":"Chin J Cancer"},{"key":"10.1002\/jcb.25908-BIB0019|jcb25908-cit-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade","volume":"18","author":"Kathawala","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1002\/jcb.25908-BIB0020|jcb25908-cit-0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1535-7163.MCT-13-0743","article-title":"Masitinib antagonizes ATP-Binding cassette subfamily C member 10-Mediated paclitaxel resistance: A preclinical study","volume":"13","author":"Kathawala","year":"2014b","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jcb.25908-BIB0021|jcb25908-cit-0021","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bcp.2012.06.019","article-title":"OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance","volume":"84","author":"Kuang","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jcb.25908-BIB0022|jcb25908-cit-0022","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-06-2414","article-title":"A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients","volume":"13","author":"Kuppens","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0023|jcb25908-cit-0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2009.11.008","article-title":"Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel","volume":"627","author":"Kwak","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jcb.25908-BIB0024|jcb25908-cit-0024","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1002\/jcb.25908-BIB0025|jcb25908-cit-0025","first-page":"1","article-title":"Human ABC G2: Structure, function, and its role in multidrug resistance","volume":"3","author":"Mo","year":"2012","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1002\/jcb.25908-BIB0026|jcb25908-cit-0026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/jm00105a067","article-title":"Non-steroidal antiandrogens. Design of novel compounds based on an infrared study of the dominant conformation and hydrogen-bonding properties of a series of anilide antiandrogens","volume":"34","author":"Morris","year":"1991","journal-title":"J Med Chem"},{"key":"10.1002\/jcb.25908-BIB0027|jcb25908-cit-0027","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/10428190701190169","article-title":"Phase I\/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma","volume":"48","author":"Morschhauser","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1002\/jcb.25908-BIB0028|jcb25908-cit-0028","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1021\/jm960365n","article-title":"N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region","volume":"39","author":"Ohnmacht","year":"1996","journal-title":"J Med Chem"},{"key":"10.1002\/jcb.25908-BIB0029|jcb25908-cit-0029","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drup.2005.02.002","article-title":"Tyrosine kinase inhibitor resistance in cancer: Role of ABC multidrug transporters","volume":"8","author":"Ozvegy-Laczka","year":"2005","journal-title":"Drug Resist Updat"},{"key":"10.1002\/jcb.25908-BIB0030|jcb25908-cit-0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/dmd.107.018374","article-title":"The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions","volume":"36","author":"Polli","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jcb.25908-BIB0031|jcb25908-cit-0031","first-page":"47","article-title":"Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein","volume":"60","author":"Rabindran","year":"2000","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0032|jcb25908-cit-0032","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6601370","article-title":"Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity","volume":"89","author":"Robey","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1002\/jcb.25908-BIB0033|jcb25908-cit-0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2736(01)00308-X","article-title":"A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)","volume":"1512","author":"Robey","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jcb.25908-BIB0034|jcb25908-cit-0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABC G2: Determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1002\/jcb.25908-BIB0035|jcb25908-cit-0035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bcp.2007.12.001","article-title":"Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))","volume":"75","author":"Robey","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jcb.25908-BIB0036|jcb25908-cit-0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4161\/cbt.5.1.2236","article-title":"Reversal of MDR1\/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo","volume":"5","author":"Shi","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/jcb.25908-BIB0037|jcb25908-cit-0037","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1158\/0008-5472.CAN-11-0375","article-title":"Roles of sildenafil in enhancing drug sensitivity in cancer","volume":"71","author":"Shi","year":"2011","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0038|jcb25908-cit-0038","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bcp.2008.11.007","article-title":"Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478","volume":"77","author":"Shi","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jcb.25908-BIB0039|jcb25908-cit-0039","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945011795378540","article-title":"Improving cancer chemotherapy with modulators of ABC drug transporters","volume":"12","author":"Shukla","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1002\/jcb.25908-BIB0040|jcb25908-cit-0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.leu.2404897","article-title":"Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2","volume":"22","author":"Shukla","year":"2008","journal-title":"Leukemia"},{"key":"10.1002\/jcb.25908-BIB0041|jcb25908-cit-0041","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5732\/cjc.011.10329","article-title":"Multidrug resistance associated proteins in multidrug resistance","volume":"31","author":"Sodani","year":"2012","journal-title":"Chin J Cancer"},{"key":"10.1002\/jcb.25908-BIB0042|jcb25908-cit-0042","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/mol.113.088609","article-title":"Molecular pharmacology of ABCG2 and its role in chemoresistance","volume":"84","author":"Stacy","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1002\/jcb.25908-BIB0043|jcb25908-cit-0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5732\/cjc.011.10466","article-title":"Role of ABC transporters in cancer chemotherapy","volume":"31","author":"Sun","year":"2012","journal-title":"Chin J Cancer"},{"key":"10.1002\/jcb.25908-BIB0044|jcb25908-cit-0044","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/138920111795164048","article-title":"Revisiting the ABCs of multidrug resistance in cancer chemotherapy","volume":"12","author":"Tiwari","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1002\/jcb.25908-BIB0045|jcb25908-cit-0045","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0046|jcb25908-cit-0046","first-page":"5035","article-title":"Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance","volume":"62","author":"Volk","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25908-BIB0047|jcb25908-cit-0047","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bcp.2014.06.006","article-title":"Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCBI","volume":"90","author":"Wang","year":"2014a","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jcb.25908-BIB0048|jcb25908-cit-0048","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/cancers6041925","article-title":"Repositioning of tyrosine kinase inhibitors as antagonists of ATP-Binding cassette transporters in anticancer drug resistance","volume":"6","author":"Wang","year":"2014b","journal-title":"Cancers (Basel)"},{"key":"10.1002\/jcb.25908-BIB0049|jcb25908-cit-0049","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2217\/fon.13.253","article-title":"Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP)","volume":"10","author":"Yang","year":"2013","journal-title":"Future Oncol"},{"key":"10.1002\/jcb.25908-BIB0050|jcb25908-cit-0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biocel.2014.03.026","article-title":"Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance","volume":"51","author":"Zhang","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1002\/jcb.25908-BIB0051|jcb25908-cit-0051","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1021\/jo8017186","article-title":"The use of formamidine protection for the derivatization of aminobenzoic acids","volume":"73","author":"Zhichkin","year":"2008","journal-title":"J Org Chem"}],"container-title":["Journal of Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcb.25908","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcb.25908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:33:48Z","timestamp":1658500428000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcb.25908"}},"subtitle":["N\n                    <scp>OVEL<\/scp>\n                    ABCG2 I\n                    <scp>NHIBITORS<\/scp>"],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/jcb.25908","archive":["Portico"],"relation":{},"ISSN":["0730-2312"],"issn-type":[{"value":"0730-2312","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}